Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis

Patients with diabetes have been reported to have enhanced susceptibility to severe or fatal COVID-19 infections, including a high risk of being admitted to intensive care units with respiratory failure and septic complications. Given the global prevalence of diabetes, affecting over 450 million peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabelli, Maria, Chiefari, Eusebio, Puccio, Luigi, Foti, Daniela Patrizia, Brunetti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277613/
https://www.ncbi.nlm.nih.gov/pubmed/32456064
http://dx.doi.org/10.3390/ijerph17103664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277613/
https://www.ncbi.nlm.nih.gov/pubmed/32456064
http://dx.doi.org/10.3390/ijerph17103664

Ejemplares similares